Home›Ledipasvir›Ledipasvir + Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox

Does Ledipasvir Interact with Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox?

Ledipasvir and Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox have a unknown drug interaction according to U.S. FDA drug labeling data. Hepatitis C Antiviral Agents: ledipasvir/sofosbuvir sofosbuvir/velpatasvir sofosbuvir/velpatasvir/voxilaprevir ↑ tenofovir The safety of increased tenofovir concentrations in the setting of HARVONI ® (ledipasvir/sofosbuvir) and STRIBILD has not been established. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity: Unknown
Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox Class: Cytochrome P450 3A Inhibitor
Management: Consult your pharmacist
Data Source: U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Ledipasvir and your doctor is considering prescribing Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox (or vice versa), make sure to:

Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
Ask whether the benefits of combining these medications outweigh the risks for your specific situation
Ask what symptoms to watch for that would indicate the interaction is causing problems
Never stop or change either medication without first consulting your healthcare provider

💊 Ledipasvir(Harvoni)+💊 Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox(Stribild)

Severity & Interaction Details

ℹ️

unknown

Interaction documented — severity unclassified

The FDA label notes an interaction but the severity is not classified in our dataset.

Severity scale

MinorContra

On record

Yes

Drug A class

—

Drug B class

Cytochrome P450 3A Inhibitor

Source

FDA drug label - elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate

What this means in plain English

Hepatitis C Antiviral Agents: ledipasvir/sofosbuvir sofosbuvir/velpatasvir sofosbuvir/velpatasvir/voxilaprevir ↑ tenofovir The safety of increased tenofovir concentrations in the setting of HARVONI ® (ledipasvir/sofosbuvir) and STRIBILD has not been established.

About Ledipasvir and Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox

Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox is a Cytochrome P450 3A Inhibitor. You may recognize them by the brand names Harvoni and Stribild. Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox is taken by mouth. Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

FDA

FDA Safety Alert: Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only,about Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox · 2026-02

PubMed

A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal, West Africa.about Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox · 2018-10

PubMed

Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI.about Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox · 2017-07

Share this result:

WhatsApp Text / SMS Email

Also share on:X Facebook

Add more drugs

Check Ledipasvir and Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.